Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-266435

Director sold 600 shares at an average $241.70 ($145,017)

  • Director acquired 1,429 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Mahony Susan · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-08 Exercise or conversion : show line 1 in the form 10b5-1 +1,429 1,429 D
2026-06-09 Sale : show line 2 in the form 10b5-1 −300 $237.21 $71,163 1,129 D
2026-06-10 Sale : show line 3 in the form 10b5-1 −300 $246.18 $73,854 829 D
Open-market sales · 600 sh · avg $241.70 · $145,017

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-08 Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Units −1,429 0 D
Loading xslF345X06/ownership.xml…